SoftBank invested $150m to lead PolicyBazaar and PaisaBazaar owner ETechAces’ series F round, which included InfoEdge.
Month: June 2018
Kezar kicks into public markets
Onyx Therapeutics-backed autoimmune drug developer Kezar Life Sciences has closed its initial public offering at $86.3m.
Evergrande fetches $860m Faraday Future stake
Evergrande Health Industry has paid $860m for the 45% stake in Faraday Future owned by Season Smart, as US regulators approve a $2bn total investment.
AppNexus takes acquisition call from AT&T
WPP, News Corp, Microsoft and Deutsche Telekom will exit adtech provider AppNexus in a purchase that is reportedly worth about $1.6bn.
Microsoft bonds with Bonsai
The artificial intelligence technology developer is set to be acquired by investor Microsoft in a deal that will also allow Samsung, Siemens and ABB to exit.
Seraphim sets out stall for accelerator
The corporate-backed Space Camp Accelerator has welcomed its first six startups.
TouchBistro completes $54m series D order
Existing investor Recruit Holdings took part in a round that will fund the next iteration of TouchBistro’s restaurant POS system.
Aaptiv activates $22m series C
NWS Holdings, Disney, Warner Music and Amazon Alexa Fund all contributed to a round that increased the exercise app’s overall funding to $52m.
Beamery transports in $28m
Edenred and Microsoft unit M12 took part in an EQT Ventures-led series B round that took the recruitment software provider’s total funding to $35m.
Magenta generates $100m in initial public offering
The transplant-based medicine developer, backed by Alphabet, Partners Healthcare and Access Industries, floated in the middle of its range.
QuantumScape gets $100m recharge from Volkswagen
Existing investor Volkswagen is providing $100m for the solid-state battery developer, with which it is forming a joint venture.
Meituan Dianping makes for public markets
The local services platform, which counts Tencent as its largest investor, has filed for an offering that could net more than $4bn at a $60bn valuation.
PayPal sinks $120m into Simility acquisition
Simility, a developer of fraud detection software, is set to be acquired by corporate investor PayPal for $120m.
Xeris reformulates path to IPO
Xeris Pharmaceuticals, a US-based drug formulation developer backed by drug producer Institut Mérieux, went public on Friday after issuing 5.7 million shares priced at $15 each, raising $85.5m. The company’s shares opened at $19.50 on the Nasdaq Global Market on Friday. After briefly rising to $19.84 they closed at $18.80. Xeris has developed two formulation… Continue reading Xeris reformulates path to IPO